Autophagy and Alzheimer’s Disease: From Molecular Mechanisms to Therapeutic Implications
Tóm tắt
Từ khóa
Tài liệu tham khảo
Alberts, 2002, Transport from the Trans Golgi Network to Lysosomes.
Armstrong, 2009, The molecular biology of senile plaques and neurofibrillary tangles in Alzheimer’s disease., Folia Neuropathol., 47, 289
Atkin, 2014, Ubiquitin pathways in neurodegenerative disease., Front. Mol. Neurosci., 7, 10.3389/fnmol.2014.00063
Bachhuber, 2015, Inhibition of amyloid-beta plaque formation by alpha-synuclein., Nat. Med., 21, 802, 10.1038/nm.3885
Bai, 2016, AlzBase: an integrative database for gene dysregulation in Alzheimer’s disease., Mol. Neurobiol., 53, 310, 10.1007/s12035-014-9011-3
Bai, 2014, Distinctive RNA expression profiles in blood associated with Alzheimer disease after accounting for white matter hyperintensities., Alzheimer Dis. Assoc. Disord., 28, 226, 10.1097/WAD.0000000000000022
Baig, 2012, Clusterin mRNA and protein in Alzheimer’s disease., J. Alzheimers Dis., 28, 337, 10.3233/JAD-2011-110473
Bandyopadhyay, 2010, Identification of regulators of chaperone-mediated autophagy., Mol. Cell, 39, 535, 10.1016/j.molcel.2010.08.004
Barral, 2012, Genotype patterns at PICALM, CR1 BIN1 CLU, and APOE genes are associated with episodic memory., Neurology, 78, 1464, 10.1212/WNL.0b013e3182553c48
Basu, 2004, Interleukin-1: a master regulator of neuroinflammation., J. Neurosci. Res., 78, 151, 10.1002/jnr.20266
Bateman, 2006, Human amyloid-beta synthesis and clearance rates as measured in cerebrospinal fluid in vivo., Nat. Med., 12, 856, 10.1038/nm1438
Bedse, 2014, Altered expression of the CB1 cannabinoid receptor in the triple transgenic mouse model of Alzheimer’s disease., J. Alzheimers Dis., 40, 701, 10.3233/JAD-131910
Bedse, 2015, The role of endocannabinoid signaling in the molecular mechanisms of neurodegeneration in Alzheimer’s disease., J. Alzheimers Dis., 43, 1115, 10.3233/JAD-141635
Beeg, 2016, Clusterin binds to Abeta1-42 oligomers with high affinity and interferes with peptide aggregation by inhibiting primary and secondary nucleation., J. Biol. Chem., 291, 6958, 10.1074/jbc.M115.689539
Benito, 2003, Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer’s disease brains., J. Neurosci., 23, 11136, 10.1523/JNEUROSCI.23-35-11136.2003
Bertram, 2007, Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database., Nat. Genet., 39, 17, 10.1038/ng1934
Bhaskar, 2010, Regulation of tau pathology by the microglial fractalkine receptor., Neuron, 68, 19, 10.1016/j.neuron.2010.08.023
Bian, 2002, Axonopathy, tau abnormalities, and dyskinesia, but no neurofibrillary tangles in p25-transgenic mice., J. Comp. Neurol., 446, 257, 10.1002/cne.10186
Bloom, 2014, Amyloid-beta and tau: the trigger and bullet in Alzheimer disease pathogenesis., JAMA Neurol., 71, 505, 10.1001/jamaneurol.2013.5847
Boland, 2008, Autophagy induction and autophagosome clearance in neurons: relationship to autophagic pathology in Alzheimer’s disease., J. Neurosci., 28, 6926, 10.1523/JNEUROSCI.0800-08.2008
Braskie, 2011, Common Alzheimer’s disease risk variant within the CLU gene affects white matter microstructure in young adults., J. Neurosci., 31, 6764, 10.1523/JNEUROSCI.5794-10.2011
Caccamo, 2014, Genetic reduction of mammalian target of rapamycin ameliorates Alzheimer’s disease-like cognitive and pathological deficits by restoring hippocampal gene expression signature., J. Neurosci., 34, 7988, 10.1523/JNEUROSCI.0777-14.2014
Caccamo, 2013, mTOR regulates tau phosphorylation and degradation: implications for Alzheimer’s disease and other tauopathies., Aging Cell, 12, 370, 10.1111/acel.12057
Caccamo, 2010, Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-beta, and Tau: effects on cognitive impairments., J. Biol. Chem., 285, 13107, 10.1074/jbc.M110.100420
Cai, 2015, Autophagy dysfunction upregulates beta-amyloid peptides via enhancing the activity of gamma-secretase complex., Neuropsychiatr. Dis. Treat., 11, 2091, 10.2147/NDT.S84755
Carson, 2006, The cellular response in neuroinflammation: the role of leukocytes, microglia and astrocytes in neuronal death and survival., Clin. Neurosci. Res., 6, 237, 10.1016/j.cnr.2006.09.004
Carvalho, 2015, Alzheimer’s disease and type 2 diabetes-related alterations in brain mitochondria, autophagy and synaptic markers., Biochim. Biophys. Acta, 1852, 1665, 10.1016/j.bbadis.2015.05.001
Cataldo, 2004, Presenilin mutations in familial Alzheimer disease and transgenic mouse models accelerate neuronal lysosomal pathology., J. Neuropathol. Exp. Neurol., 63, 821, 10.1093/jnen/63.8.821
Cavieres, 2015, Tetrahydrohyperforin inhibits the proteolytic processing of amyloid precursor protein and enhances its degradation by Atg5-dependent autophagy., PLOS ONE, 10, 10.1371/journal.pone.0136313
Cerpa, 2010, The hyperforin derivative IDN5706 occludes spatial memory impairments and neuropathological changes in a double transgenic Alzheimer’s mouse model., Curr. Alzheimer Res., 7, 126, 10.2174/156720510790691218
Chan, 2016, Interference of alpha-synuclein uptake by monomeric beta-Amyloid1-40 and potential core acting site of the interference., Neurotox. Res., 30, 479, 10.1007/s12640-016-9644-2
Chang, 2012, Deregulated Cdk5 triggers aberrant activation of cell cycle kinases and phosphatases inducing neuronal death., J. Cell Sci., 125, 5124, 10.1242/jcs.108183
Chau, 2015, Latrepirdine for Alzheimer’s disease., Cochrane Database Syst. Rev., 4, 10.1002/14651858.CD009524.pub2
Chen, 2004, Content-rich biological network constructed by mining PubMed abstracts., BMC Bioinformatics, 5, 10.1186/1471-2105-5-147
Chen, 2013, Mass spectrometry assessment of ubiquitin carboxyl-terminal hydrolase L1 partitioning between soluble and particulate brain homogenate fractions., Anal. Chem., 85, 6011, 10.1021/ac400831z
Cheng, 2017, Haplodeficiency of Cathepsin D does not affect cerebral amyloidosis and autophagy in APP/PS1 transgenic mice., J. Neurochem., 142, 297, 10.1111/jnc.14048
Cho, 2015, SUMO1 promotes Abeta production via the modulation of autophagy., Autophagy, 11, 100, 10.4161/15548627.2014.984283
Choi, 2004, Oxidative modifications and down-regulation of ubiquitin carboxyl-terminal hydrolase L1 associated with idiopathic Parkinson’s and Alzheimer’s diseases., J. Biol. Chem., 279, 13256, 10.1074/jbc.M314124200
Chu, 2013, Induction of autophagy by a novel small molecule improves a beta pathology and ameliorates cognitive deficits., PLOS ONE, 8, 10.1371/journal.pone.0065367
Ciechanover, 1998, The ubiquitin-proteasome pathway: the complexity and myriad functions of proteins death., Proc. Natl. Acad. Sci. U.S.A., 95, 2727, 10.1073/pnas.95.6.2727
Clementi, 2006, Alzheimer’s amyloid beta-peptide (1-42) induces cell death in human neuroblastoma via bax/bcl-2 ratio increase: an intriguing role for methionine 35., Biochem. Biophys. Res. Commun., 342, 206, 10.1016/j.bbrc.2006.01.137
Colasanti, 2014, Role of alpha-synuclein in autophagy modulation of primary human T lymphocytes., Cell Death Dis., 5, 10.1038/cddis.2014.211
Corsetti, 2015, NH2-truncated human tau induces deregulated mitophagy in neurons by aberrant recruitment of Parkin and UCHL-1: implications in Alzheimer’s disease., Hum. Mol. Genet., 24, 3058, 10.1093/hmg/ddv059
Costes, 2014, UCHL1 deficiency exacerbates human islet amyloid polypeptide toxicity in beta-cells: evidence of interplay between the ubiquitin/proteasome system and autophagy., Autophagy, 10, 1004, 10.4161/auto.28478
Crews, 2011, Modulation of aberrant CDK5 signaling rescues impaired neurogenesis in models of Alzheimer’s disease., Cell Death Dis., 2, 10.1038/cddis.2011.2
Crews, 2010, Selective molecular alterations in the autophagy pathway in patients with Lewy body disease and in models of alpha-synucleinopathy., PLOS ONE, 5, 10.1371/journal.pone.0009313
De Duve, 1966, Functions of lysosomes., Annu. Rev. Physiol., 28, 435, 10.1146/annurev.ph.28.030166.002251
De Strooper, 1998, Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein., Nature, 391, 387, 10.1038/34910
Dean, 1975, Direct evidence of importance of lysosomes in degradation of intracellular proteins., Nature, 257, 414, 10.1038/257414a0
Decuypere, 2012, Regulation of the autophagic bcl-2/beclin 1 interaction., Cells, 1, 284, 10.3390/cells1030284
Deming, 2016, A potential endophenotype for Alzheimer’s disease: cerebrospinal fluid clusterin., Neurobiol. Aging, 37, e1, 10.1016/j.neurobiolaging.2015.09.009
Deng, 2016, beta-asarone improves learning and memory and reduces Acetyl Cholinesterase and Beta-amyloid 42 levels in APP/PS1 transgenic mice by regulating Beclin-1-dependent autophagy., Brain Res., 1652, 188, 10.1016/j.brainres.2016.10.008
Dickson, 1999, Neurochemical diversity of dystrophic neurites in the early and late stages of Alzheimer’s disease., Exp. Neurol., 156, 100, 10.1006/exnr.1998.7010
Dolan, 2010, A caspase cleaved form of tau is preferentially degraded through the autophagy pathway., J. Biol. Chem., 285, 21978, 10.1074/jbc.M110.110940
Donovan, 2012, Analysis of a membrane-enriched proteome from postmortem human brain tissue in Alzheimer’s disease., Proteomics Clin. Appl., 6, 201, 10.1002/prca.201100068
Du, 2017, Neuroinflammation contributes to autophagy flux blockage in the neurons of rostral ventrolateral medulla in stress-induced hypertension rats., J. Neuroinflammation, 14, 10.1186/s12974-017-0942-2
Du, 2013, Trehalose rescues Alzheimer’s disease phenotypes in APP/PS1 transgenic mice., J. Pharm. Pharmacol., 65, 1753, 10.1111/jphp.12108
Ferreiro, 2007, Bcl-2 overexpression protects against amyloid-beta and prion toxicity in GT1-7 neural cells., J. Alzheimers Dis., 12, 223, 10.3233/JAD-2007-12303
Forlenza, 2012, Does lithium prevent Alzheimer’s disease?, Drugs Aging, 29, 335, 10.2165/11599180-000000000-00000
Francois, 2014, Longitudinal follow-up of autophagy and inflammation in brain of APPswePS1dE9 transgenic mice., J. Neuroinflammation, 11, 10.1186/s12974-014-0139-x
Francois, 2013, Involvement of interleukin-1beta in the autophagic process of microglia: relevance to Alzheimer’s disease., J. Neuroinflammation, 10, 10.1186/1742-2094-10-151
Frederick, 2015, Rapamycin ester analog CCI-779/Temsirolimus alleviates tau pathology and improves motor deficit in mutant tau transgenic mice., J. Alzheimers Dis., 44, 1145, 10.3233/JAD-142097
Funakoshi, 1997, Analyses of APG13 gene involved in autophagy in yeast, Saccharomyces cerevisiae., Gene, 192, 207, 10.1016/S0378-1119(97)00031-0
Funderburk, 2010, Cell “self-eating” (autophagy) mechanism in Alzheimer’s disease., Mt. Sinai J. Med., 77, 59, 10.1002/msj.20161
Garcia-Arencibia, 2010, Autophagy, a guardian against neurodegeneration., Semin. Cell Dev. Biol., 21, 691, 10.1016/j.semcdb.2010.02.008
Giasson, 2003, Initiation and synergistic fibrillization of tau and alpha-synuclein., Science, 300, 636, 10.1126/science.1082324
Gong, 2006, Ubiquitin hydrolase Uch-L1 rescues beta-amyloid-induced decreases in synaptic function and contextual memory., Cell, 126, 775, 10.1016/j.cell.2006.06.046
Gong, 2013, Nicotinamide riboside restores cognition through an upregulation of proliferator-activated receptor-gamma coactivator 1alpha regulated beta-secretase 1 degradation and mitochondrial gene expression in Alzheimer’s mouse models., Neurobiol. Aging, 34, 1581, 10.1016/j.neurobiolaging.2012.12.005
Grill, 2017, Nicotinamide as an Early Alzheimer’s Disease Treatment (NEAT).
Grossi, 2013, The polyphenol oleuropein aglycone protects TgCRND8 mice against Ass plaque pathology., PLOS ONE, 8, 10.1371/journal.pone.0071702
Guglielmotto, 2012, Abeta1-42-mediated down-regulation of Uch-L1 is dependent on NF-kappaB activation and impaired BACE1 lysosomal degradation., Aging Cell, 11, 834, 10.1111/j.1474-9726.2012.00854.x
Harrison, 2009, Rapamycin fed late in life extends lifespan in genetically heterogeneous mice., Nature, 460, 392, 10.1038/nature08221
Hiebel, 2014, Cannabinoid receptor 1 modulates the autophagic flux independent of mTOR- and BECLIN1-complex., J. Neurochem., 131, 484, 10.1111/jnc.12839
Higuchi, 2010, The cannabinoid 1-receptor silent antagonist O-2050 attenuates preference for high-fat diet and activated astrocytes in mice., J. Pharmacol. Sci., 112, 369, 10.1254/jphs.09326SC
Hiltunen, 2006, Ubiquilin 1 modulates amyloid precursor protein trafficking and Abeta secretion., J. Biol. Chem., 281, 32240, 10.1074/jbc.M603106200
Huber, 2016, Lysosomal signaling in control of degradation pathways., Curr. Opin. Cell Biol., 39, 8, 10.1016/j.ceb.2016.01.006
Hubert, 2016, LAMP-2 is required for incorporating syntaxin-17 into autophagosomes and for their fusion with lysosomes., Biol. Open, 5, 1516, 10.1242/bio.018648
Iijima, 2000, Neuron-specific phosphorylation of Alzheimer’s beta-amyloid precursor protein by cyclin-dependent kinase 5., J. Neurochem., 75, 1085, 10.1046/j.1471-4159.2000.0751085.x
Ikeda, 2013, Cerebrospinal fluid levels of phosphorylated tau and Abeta1-38/Abeta1-40/Abeta1-42 in Alzheimer’s disease with PS1 mutations., Amyloid, 20, 107, 10.3109/13506129.2013.790810
Inestrosa, 2011, Tetrahydrohyperforin prevents cognitive deficit, A beta deposition, tau phosphorylation and synaptotoxicity in the APPswe/PSEN1DeltaE9 model of Alzheimer’s disease: a possible effect on APP processing., Transl. Psychiatry, 1, 10.1038/tp.2011.19
Inoue, 2012, Macroautophagy deficiency mediates age-dependent neurodegeneration through a phospho-tau pathway., Mol. Neurodegener., 7, 10.1186/1750-1326-7-48
Iqbal, 2010, Tau in Alzheimer disease and related tauopathies., Curr. Alzheimer Res., 7, 656, 10.2174/156720510793611592
Irvine, 2008, Protein aggregation in the brain: the molecular basis for Alzheimer’s and Parkinson’s diseases., Mol. Med., 14, 451, 10.2119/2007-00100.Irvine
Ishiki, 2016, Glial fibrillar acidic protein in the cerebrospinal fluid of Alzheimer’s disease, dementia with Lewy bodies, and frontotemporal lobar degeneration., J. Neurochem., 136, 258, 10.1111/jnc.13399
Jellinger, 2010, Basic mechanisms of neurodegeneration: a critical update., J. Cell Mol. Med., 14, 457, 10.1111/j.1582-4934.2010.01010.x
Jiang, 2017, Salvianolic acid B protects against lipopolysaccharide-induced behavioral deficits and neuroinflammatory response: involvement of autophagy and NLRP3 inflammasome., J. Neuroinflammation, 14, 10.1186/s12974-017-1013-4
Jiang, 2014, Temsirolimus promotes autophagic clearance of amyloid-beta and provides protective effects in cellular and animal models of Alzheimer’s disease., Pharmacol. Res., 81, 54, 10.1016/j.phrs.2014.02.008
Jourquin, 2012, GLAD4U: deriving and prioritizing gene lists from PubMed literature., BMC Genomics, 10.1186/1471-2164-13-S8-S20
Kabeya, 2000, LC3 a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing., EMBO J., 19, 5720, 10.1093/emboj/19.21.5720
Kamada, 2000, Tor-mediated induction of autophagy via an Apg1 protein kinase complex., J. Cell Biol., 150, 1507, 10.1083/jcb.150.6.1507
Kamphuis, 2014, Glial fibrillary acidic protein isoform expression in plaque related astrogliosis in Alzheimer’s disease., Neurobiol. Aging, 35, 492, 10.1016/j.neurobiolaging.2013.09.035
Kanehisa, 2017, KEGG: new perspectives on genomes, pathways, diseases and drugs., Nucleic Acids Res., 45, D353, 10.1093/nar/gkw1092
Karch, 2015, Alzheimer’s disease risk genes and mechanisms of disease pathogenesis., Biol. Psychiatry, 77, 43, 10.1016/j.biopsych.2014.05.006
Katona, 2012, Multiple functions of endocannabinoid signaling in the brain., Annu. Rev. Neurosci., 35, 529, 10.1146/annurev-neuro-062111-150420
Kaushik, 2012, Chaperone-mediated autophagy: a unique way to enter the lysosome world., Trends Cell Biol., 22, 407, 10.1016/j.tcb.2012.05.006
Kickstein, 2010, Biguanide metformin acts on tau phosphorylation via mTOR/protein phosphatase 2A (PP2A) signaling., Proc. Natl. Acad. Sci. U.S.A., 107, 21830, 10.1073/pnas.0912793107
Klionsky, 2008, Autophagy revisited: a conversation with Christian de Duve., Autophagy, 4, 740, 10.4161/auto.6398
Klionsky, 2003, A unified nomenclature for yeast autophagy-related genes., Dev. Cell, 5, 539, 10.1016/S1534-5807(03)00296-X
Korff, 2013, alpha-Synuclein in cerebrospinal fluid of Alzheimer’s disease and mild cognitive impairment., J. Alzheimers Dis., 36, 679, 10.3233/JAD-130458
Korolainen, 2005, Proteomic analysis of glial fibrillary acidic protein in Alzheimer’s disease and aging brain., Neurobiol. Dis., 20, 858, 10.1016/j.nbd.2005.05.021
Kruger, 2012, Autophagic degradation of tau in primary neurons and its enhancement by trehalose., Neurobiol. Aging, 33, 2291, 10.1016/j.neurobiolaging.2011.11.009
Kuma, 2004, The role of autophagy during the early neonatal starvation period., Nature, 432, 1032, 10.1038/nature03029
Larson, 2012, Soluble alpha-synuclein is a novel modulator of Alzheimer’s disease pathophysiology., J. Neurosci., 32, 10253, 10.1523/JNEUROSCI.0581-12.2012
Lee, 2007, ESCRT-III dysfunction causes autophagosome accumulation and neurodegeneration., Curr. Biol., 17, 1561, 10.1016/j.cub.2007.07.029
Lee, 2010, Lysosomal proteolysis and autophagy require presenilin 1 and are disrupted by Alzheimer-related PS1 mutations., Cell, 141, 1146, 10.1016/j.cell.2010.05.008
Letronne, 2016, ADAM30 downregulates APP-linked defects through cathepsin D activation in Alzheimer’s disease., EBioMedicine, 9, 278, 10.1016/j.ebiom.2016.06.002
Li, 2012, Metformin attenuates Alzheimer’s disease-like neuropathology in obese, leptin-resistant mice., Pharmacol. Biochem. Behav., 101, 564, 10.1016/j.pbb.2012.03.002
Li, 2013, Autophagy enhancer carbamazepine alleviates memory deficits and cerebral amyloid-beta pathology in a mouse model of Alzheimer’s disease., Curr. Alzheimer Res., 10, 433, 10.2174/1567205011310040008
Li, 2009, The yeast lysosome-like vacuole: endpoint and crossroads., Biochim. Biophys. Acta, 1793, 650, 10.1016/j.bbamcr.2008.08.003
Li, 2006, Cyclin-dependent protein kinase 5 primes microtubule-associated protein tau site-specifically for glycogen synthase kinase 3beta., Biochemistry, 45, 3134, 10.1021/bi051635j
Li, 2008, Polyubiquitin chains: functions, structures, and mechanisms., Cell Mol. Life. Sci., 65, 2397, 10.1007/s00018-008-8090-6
Lilienbaum, 2013, Relationship between the proteasomal system and autophagy., Int. J. Biochem. Mol. Biol., 4, 1
Liu, 2013, Nicotinamide forestalls pathology and cognitive decline in Alzheimer mice: evidence for improved neuronal bioenergetics and autophagy procession., Neurobiol. Aging, 34, 1564, 10.1016/j.neurobiolaging.2012.11.020
Liu, 2014, The CLU gene rs11136000 variant is significantly associated with Alzheimer’s disease in Caucasian and Asian populations., Neuromolecular Med., 16, 52, 10.1007/s12017-013-8250-1
Liu, 2005, Trehalose differentially inhibits aggregation and neurotoxicity of beta-amyloid 40 and 42., Neurobiol. Dis., 20, 74, 10.1016/j.nbd.2005.02.003
Liu, 2016, Neuroprotective effect of beta-asarone against Alzheimer’s disease: regulation of synaptic plasticity by increased expression of SYP and GluR1., Drug Des. Devel. Ther., 10, 1461, 10.2147/DDDT.S93559
Lu, 2014, BDNF and synaptic plasticity, cognitive function, and dysfunction., Handb. Exp. Pharmacol., 220, 223, 10.1007/978-3-642-45106-5_9
Luccarini, 2015, Oleuropein aglycone protects against pyroglutamylated-3 amyloid-ss toxicity: biochemical, epigenetic and functional correlates., Neurobiol. Aging, 36, 648, 10.1016/j.neurobiolaging.2014.08.029
Lucin, 2013, Microglial beclin 1 regulates retromer trafficking and phagocytosis and is impaired in Alzheimer’s disease., Neuron, 79, 873, 10.1016/j.neuron.2013.06.046
Majd, 2013, Reciprocal induction between alpha-synuclein and beta-amyloid in adult rat neurons., Neurotox. Res., 23, 69, 10.1007/s12640-012-9330-y
Manuel, 2014, Type-1 cannabinoid receptor activity during Alzheimer’s disease progression., J. Alzheimers Dis., 42, 761, 10.3233/JAD-140492
Maphis, 2015, Loss of tau rescues inflammation-mediated neurodegeneration., Front. Neurosci., 9, 10.3389/fnins.2015.00196
Maroof, 2013, Endocannabinoid signalling in Alzheimer’s disease., Biochem. Soc. Trans., 41, 1583, 10.1042/BST20130140
Martorell, 2016, Potential therapeutic effects of oleuropein aglycone in Alzheimer’s disease., Curr. Pharm. Biotechnol., 17, 994, 10.2174/1389201017666160725120656
Marzella, 1981, Autophagy, heterophagy, microautophagy and crinophagy as the means for intracellular degradation., Virchows Arch. B Cell Pathol. Incl. Mol. Pathol., 36, 219, 10.1007/BF02912068
Matsubara, 2001, Genetic association between Alzheimer disease and the alpha-synuclein gene., Dement. Geriatr. Cogn. Disord., 12, 106, 10.1159/000051243
Matsunaga, , Lithium as a treatment for Alzheimer’s disease: a systematic review and meta-analysis., J. Alzheimers Dis., 48, 403, 10.3233/JAD-150437
Matsunaga, , Memantine monotherapy for Alzheimer’s disease: a systematic review and meta-analysis., PLOS ONE, 10, 10.1371/journal.pone.0123289
Matsuura, 1997, Apg1p, a novel protein kinase required for the autophagic process in Saccharomyces cerevisiae., Gene, 192, 245, 10.1016/S0378-1119(97)00084-X
May, 1990, Dynamics of gene expression for a hippocampal glycoprotein elevated in Alzheimer’s disease and in response to experimental lesions in rat., Neuron, 5, 831, 10.1016/0896-6273(90)90342-D
McDermott, 1996, Degradation of Alzheimer’s beta-amyloid protein by human cathepsin D., Neuroreport, 7, 2163, 10.1097/00001756-199609020-00021
Meijer, 2015, Regulation of autophagy by amino acids and MTOR-dependent signal transduction., Amino Acids, 47, 2037, 10.1007/s00726-014-1765-4
Melendez, 2008, The cell biology of autophagy in metazoans: a developing story., Development, 135, 2347, 10.1242/dev.016105
Messai, 2014, ITPR1 protects renal cancer cells against natural killer cells by inducing autophagy., Cancer Res., 74, 6820, 10.1158/0008-5472.CAN-14-0303
Metcalf, 2012, Autophagy and misfolded proteins in neurodegeneration., Exp. Neurol., 238, 22, 10.1016/j.expneurol.2010.11.003
Miners, 2017, Clusterin levels are increased in Alzheimer’s disease and influence the regional distribution of Abeta., Brain Pathol., 27, 305, 10.1111/bpa.12392
Mirnics, 2008, Molecular signatures of neurodegeneration in the cortex of PS1/PS2 double knockout mice., Mol. Neurodegener., 3, 10.1186/1750-1326-3-14
Mizushima, 2011, Autophagy: renovation of cells and tissues., Cell, 147, 728, 10.1016/j.cell.2011.10.026
Mizushima, 2004, In vivo analysis of autophagy in response to nutrient starvation using transgenic mice expressing a fluorescent autophagosome marker., Mol. Biol. Cell, 15, 1101, 10.1091/mbc.E03-09-0704
Mo, 2014, Lack of association between cathepsin D C224T polymorphism and Alzheimer’s disease risk: an update meta-analysis., BMC Neurol., 14, 10.1186/1471-2377-14-13
Mohammadi, 2016, Reduction of autophagy markers mediated protective effects of JNK inhibitor and bucladesine on memory deficit induced by A beta in rats., Naunyn Schmiedebergs Arch. Pharmacol., 389, 501, 10.1007/s00210-016-1222-x
Mulder, 2014, Apolipoproteins E and J interfere with amyloid-beta uptake by primary human astrocytes and microglia in vitro., Glia, 62, 493, 10.1002/glia.22619
Mullan, 2013, Plasma clusterin levels and the rs11136000 genotype in individuals with mild cognitive impairment and Alzheimer’s disease., Curr. Alzheimer Res., 10, 973, 10.2174/15672050113106660162
Nah, 2013, BECN1/Beclin 1 is recruited into lipid rafts by prion to activate autophagy in response to amyloid beta 42., Autophagy, 9, 2009, 10.4161/auto.26118
Nakatogawa, 2013, Two ubiquitin-like conjugation systems that mediate membrane formation during autophagy., Essays Biochem., 55, 39, 10.1042/bse0550039
Nakatogawa, 2007, Atg8 a ubiquitin-like protein required for autophagosome formation, mediates membrane tethering and hemifusion., Cell, 130, 165, 10.1016/j.cell.2007.05.021
Natunen, 2016, Relationship between ubiquilin-1 and BACE1 in human Alzheimer’s disease and APdE9 transgenic mouse brain and cell-based models., Neurobiol. Dis., 85, 187, 10.1016/j.nbd.2015.11.005
N’Diaye, 2009, PLIC proteins or ubiquilins regulate autophagy-dependent cell survival during nutrient starvation., EMBO Rep., 10, 173, 10.1038/embor.2008.238
Neely, 2011, Presenilins mediate efficient proteolysis via the autophagosome-lysosome system., Autophagy, 7, 664, 10.4161/auto.7.6.15448
Nilsson, 2013, A beta secretion and plaque formation depend on autophagy., Cell Rep., 5, 61, 10.1016/j.celrep.2013.08.042
Nilsson, 2014, Dual roles for autophagy: degradation and secretion of Alzheimer’s disease Abeta peptide., Bioessays, 36, 570, 10.1002/bies.201400002
Nilsson, 2015, Autophagy-related protein 7 deficiency in amyloid beta (A beta) precursor protein transgenic mice decreases Abeta in the multivesicular bodies and induces Abeta accumulation in the Golgi., Am. J. Pathol., 185, 305, 10.1016/j.ajpath.2014.10.011
Nixon, 2007, Autophagy, amyloidogenesis and Alzheimer disease., J. Cell Sci., 120, 4081, 10.1242/jcs.019265
Nixon, 2005, Extensive involvement of autophagy in Alzheimer disease: an immuno-electron microscopy study., J. Neuropathol. Exp. Neurol., 64, 113, 10.1093/jnen/64.2.113
2017, The Nobel Prize in Physiology or Medicine 2016 [Online]. Nobel Media AB 2014.
Noble, 2003, Cdk5 is a key factor in tau aggregation and tangle formation in vivo., Neuron, 38, 555, 10.1016/S0896-6273(03)00259-9
Nowacek, 2009, Neurodegenerative disorders and nanoformulated drug development., Nanomedicine (Lond), 4, 541, 10.2217/nnm.09.37
Ntais, 2004, Meta-analysis of the association of the cathepsin D Ala224Val gene polymorphism with the risk of Alzheimer’s disease: a HuGE gene-disease association review., Am. J. Epidemiol., 159, 527, 10.1093/aje/kwh069
Oddo, 2006, A dynamic relationship between intracellular and extracellular pools of Abeta., Am. J. Pathol., 168, 184, 10.2353/ajpath.2006.050593
Oikawa, 2016, alpha-Synuclein fibrils exhibit gain of toxic function, promoting tau aggregation and inhibiting microtubule assembly., J. Biol. Chem., 291, 15046, 10.1074/jbc.M116.736355
Oksman, 2013, Transduced wild-type but not P301S mutated human tau shows hyperphosphorylation in transgenic mice overexpressing A30P mutated human alpha-synuclein., Neurodegener. Dis., 12, 91, 10.1159/000341596
Okuma, 1998, A history of investigation on the mood stabilizing effect of carbamazepine in Japan., Psychiatry Clin. Neurosci., 52, 3, 10.1111/j.1440-1819.1998.tb00966.x
Olah, 2015, Proteomic analysis of cerebrospinal fluid in Alzheimer’s disease: wanted dead or alive., J. Alzheimers Dis., 44, 1303, 10.3233/JAD-140141
Onodera, 2005, Autophagy is required for maintenance of amino acid levels and protein synthesis under nitrogen starvation., J. Biol. Chem., 280, 31582, 10.1074/jbc.M506736200
Pacheco, 2009, Tau deletion exacerbates the phenotype of Niemann-Pick type C mice and implicates autophagy in pathogenesis., Hum. Mol. Genet., 18, 956, 10.1093/hmg/ddn423
Parenti, 2013, New strategies for the treatment of lysosomal storage diseases (review)., Int. J. Mol. Med., 31, 11, 10.3892/ijmm.2012.1187
Paroni, 2014, FOXO1 locus and acetylcholinesterase inhibitors in elderly patients with Alzheimer’s disease., Clin. Interv. Aging, 9, 1783, 10.2147/CIA.S64758
Paz-Y-Miño, 2015, Positive association of the cathepsin D Ala224Val gene polymorphism with the risk of Alzheimer’s disease., Am. J. Med. Sci., 350, 296, 10.1097/MAJ.0000000000000555
Perez, 2009, Tau–an inhibitor of deacetylase HDAC6 function., J. Neurochem., 109, 1756, 10.1111/j.1471-4159.2009.06102.x
Perez, 2015, Resilience of precuneus neurotrophic signaling pathways despite amyloid pathology in prodromal Alzheimer’s disease., Biol. Psychiatry, 77, 693, 10.1016/j.biopsych.2013.12.016
Phelan, 2017, Phase II clinical trial of nicotinamide for the treatment of mild to moderate Alzheimer’s disease., J. Geriatr. Med. Gerontol., 3, 10.23937/2469-5858/1510021
Pickford, 2008, The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid beta accumulation in mice., J. Clin. Invest., 118, 2190, 10.1172/JCI33585
Piyanova, 2013, Loss of CB1 receptors leads to decreased cathepsin D levels and accelerated lipofuscin accumulation in the hippocampus., Mech. Ageing Dev., 134, 391, 10.1016/j.mad.2013.08.001
Poon, 2013, beta-Amyloid (A beta) oligomers impair brain-derived neurotrophic factor retrograde trafficking by down-regulating ubiquitin C-terminal hydrolase, UCH-L1., J. Biol. Chem., 288, 16937, 10.1074/jbc.M113.463711
Porquet, 2014, Neuroprotective role of trans-resveratrol in a murine model of familial Alzheimer’s disease., J. Alzheimers Dis., 42, 1209, 10.3233/JAD-140444
Portbury, 2017, Trehalose improves cognition in the transgenic Tg2576 mouse model of Alzheimer’s disease., J. Alzheimers Dis., 60, 549, 10.3233/JAD-170322
Posada-Duque, 2015, p35 and Rac1 underlie the neuroprotection and cognitive improvement induced by CDK5 silencing., J. Neurochem., 134, 354, 10.1111/jnc.13127
Qu, 2011, S-Nitrosylation activates Cdk5 and contributes to synaptic spine loss induced by beta-amyloid peptide., Proc. Natl. Acad. Sci. U.S.A., 108, 14330, 10.1073/pnas.1105172108
Quinn, 2012, alpha-Synuclein mRNA and soluble alpha-synuclein protein levels in post-mortem brain from patients with Parkinson’s disease, dementia with Lewy bodies, and Alzheimer’s disease., Brain Res., 1459, 71, 10.1016/j.brainres.2012.04.018
Rademakers, 2005, Association of cyclin-dependent kinase 5 and neuronal activators p35 and p39 complex in early-onset Alzheimer’s disease., Neurobiol. Aging, 26, 1145, 10.1016/j.neurobiolaging.2004.10.003
Ramirez, 2005, Prevention of Alzheimer’s disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation., J. Neurosci., 25, 1904, 10.1523/JNEUROSCI.4540-04.2005
Riemenschneider, 2006, The cathepsin D rs17571 polymorphism: effects on CSF tau concentrations in Alzheimer disease., Hum. Mutat., 27, 532, 10.1002/humu.20326
Roberts, 2017, alpha-Synuclein increases beta-amyloid secretion by promoting beta-/gamma-secretase processing of APP., PLOS ONE, 12, 10.1371/journal.pone.0171925
Rogel, 2010, The role of the ubiquitin proteasome pathway in keratin intermediate filament protein degradation., Proc. Am. Thorac. Soc., 7, 71, 10.1513/pats.200908-089JS
Rohn, 2008, Lack of pathology in a triple transgenic mouse model of Alzheimer’s disease after overexpression of the anti-apoptotic protein Bcl-2., J. Neurosci., 28, 3051, 10.1523/JNEUROSCI.5620-07.2008
Rothenberg, 2010, Ubiquilin functions in autophagy and is degraded by chaperone-mediated autophagy., Hum. Mol. Genet., 19, 3219, 10.1093/hmg/ddq231
Sadleir, 2012, Cdk5 protein inhibition and Abeta42 increase BACE1 protein level in primary neurons by a post-transcriptional mechanism: implications of CDK5 as a therapeutic target for Alzheimer disease., J. Biol. Chem., 287, 7224, 10.1074/jbc.M111.333914
Saido, 2012, Proteolytic degradation of amyloid beta-protein., Cold Spring Harb. Perspect. Med., 2, 10.1101/cshperspect.a006379
Santulli, 2015, Essential roles of intracellular calcium release channels in muscle, brain, metabolism, and aging., Curr. Mol. Pharmacol., 8, 206, 10.2174/1874467208666150507105105
Sarkar, 2007, Trehalose, a novel mTOR-independent autophagy enhancer, accelerates the clearance of mutant huntingtin and alpha-synuclein., J. Biol. Chem., 282, 5641, 10.1074/jbc.M609532200
Sarkar, 2005, Lithium induces autophagy by inhibiting inositol monophosphatase., J. Cell Biol., 170, 1101, 10.1083/jcb.200504035
Satoh, 2013, Ubiquilin-1 immunoreactivity is concentrated on Hirano bodies and dystrophic neurites in Alzheimer’s disease brains., Neuropathol. Appl. Neurobiol., 39, 817, 10.1111/nan.12036
Schuur, 2011, Cathepsin D gene and the risk of Alzheimer’s disease: a population-based study and meta-analysis., Neurobiol. Aging, 32, 1607, 10.1016/j.neurobiolaging.2009.10.011
Settembre, 2013, Signals from the lysosome: a control centre for cellular clearance and energy metabolism., Nat. Rev. Mol. Cell Biol., 14, 283, 10.1038/nrm3565
Seyb, 2007, p35/Cyclin-dependent kinase 5 is required for protection against beta-amyloid-induced cell death but not tau phosphorylation by ceramide., J. Mol. Neurosci., 31, 23, 10.1007/BF02686115
Shao, 2014, Activating cannabinoid receptor 2 alleviates pathogenesis of experimental autoimmune encephalomyelitis via activation of autophagy and inhibiting NLRP3 inflammasome., CNS Neurosci. Ther., 20, 1021, 10.1111/cns.12349
Shen, 2014, At the end of the autophagic road: an emerging understanding of lysosomal functions in autophagy., Trends Biochem. Sci., 39, 61, 10.1016/j.tibs.2013.12.001
Sheng, 2016, Cdk5 is a new rapid synaptic homeostasis regulator capable of initiating the early Alzheimer-like pathology., Cereb. Cortex, 26, 2937, 10.1093/cercor/bhv032
Shibata, 2012, Lack of genetic association of the UCHL1 gene with Alzheimer’s disease and Parkinson’s disease with dementia., Dement. Geriatr. Cogn. Disord., 33, 250, 10.1159/000339357
Shilling, 2014, Suppression of InsP3 receptor-mediated Ca2+ signaling alleviates mutant presenilin-linked familial Alzheimer’s disease pathogenesis., J. Neurosci., 34, 6910, 10.1523/JNEUROSCI.5441-13.2014
Shuai, 2015, Genetic associations of CLU rs9331888 polymorphism with Alzheimer’s disease: a meta-analysis., Neurosci. Lett., 591, 160, 10.1016/j.neulet.2015.02.040
Shukla, 2013, A truncated peptide from p35 a Cdk5 activator, prevents Alzheimer’s disease phenotypes in model mice., FASEB J., 27, 174, 10.1096/fj.12-217497
Singh, 2016, Effect of low-dose rapamycin on senescence markers and physical functioning in older adults with coronary artery disease: results of a pilot study., J Frailty Aging, 5, 204
Sofroniew, 2010, Astrocytes: biology and pathology., Acta Neuropathol., 119, 7, 10.1007/s00401-009-0619-8
Solas, 2013, CB2 receptor and amyloid pathology in frontal cortex of Alzheimer’s disease patients., Neurobiol. Aging, 34, 805, 10.1016/j.neurobiolaging.2012.06.005
Somavarapu, 2016, Loss of stability and hydrophobicity of presenilin 1 mutations causing Alzheimer’s disease., J. Neurochem., 137, 101, 10.1111/jnc.13535
Song, 2015, Anti-autophagic and anti-apoptotic effects of memantine in a SH-SY5Y cell model of Alzheimer’s disease via mammalian target of rapamycin-dependent and -independent pathways., Mol. Med. Rep., 12, 7615, 10.3892/mmr.2015.4382
Song, 2015, Enhancement of BACE1 activity by p25/Cdk5-mediated phosphorylation in Alzheimer’s disease., PLOS ONE, 10, 10.1371/journal.pone.0136950
Spilman, 2010, Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-beta levels in a mouse model of Alzheimer’s disease., PLOS ONE, 5, 10.1371/journal.pone.0009979
Steele, 2013, Modulation of autophagy as a therapeutic target for Alzheimer’s disease., Postdoc. J., 1, 21, 10.14304/SURYA.JPR.V1N2.3
Steele, 2013, Latrepirdine (Dimebon(R)), a potential Alzheimer therapeutic, regulates autophagy and neuropathology in an Alzheimer mouse model., Autophagy, 9, 617, 10.4161/auto.23487
Stevens, 2014, A gene-brain-cognition pathway for the effect of an Alzheimers risk gene on working memory in young adults., Neuropsychologia, 61, 143, 10.1016/j.neuropsychologia.2014.06.021
Stieren, 2011, Ubiquilin-1 is a molecular chaperone for the amyloid precursor protein., J. Biol. Chem., 286, 35689, 10.1074/jbc.M111.243147
Sun, 2014, Differential activation of mTOR complex 1 signaling in human brain with mild to severe Alzheimer’s disease., J. Alzheimers Dis., 38, 437, 10.3233/JAD-131124
Szklarczyk, 2017, The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible., Nucleic Acids Res., 45, D362, 10.1093/nar/gkw937
Takeshige, 1992, Autophagy in yeast demonstrated with proteinase-deficient mutants and conditions for its induction., J. Cell Biol., 119, 301, 10.1083/jcb.119.2.301
Tanaka, 2004, Ubiquitin, proteasome and parkin., Biochim. Biophys. Acta, 1695, 235, 10.1016/j.bbamcr.2004.09.026
Tang, 2015, mTor mediates tau localization and secretion: Implication for Alzheimer’s disease., Biochim. Biophys. Acta, 1853, 1646, 10.1016/j.bbamcr.2015.03.003
2016, Scientific Background Discoveries of Mechanisms for Autophagy.
Tian, 2014, Decreased expression of cathepsin D in monocytes is related to the defective degradation of amyloid-beta in Alzheimer’s disease., J. Alzheimers Dis., 42, 511, 10.3233/JAD-132192
Tian, 2011, A small-molecule enhancer of autophagy decreases levels of A beta and APP-CTF via Atg5-dependent autophagy pathway., FASEB J., 25, 1934, 10.1096/fj.10-175158
Tsukada, 1993, Isolation and characterization of autophagy-defective mutants of Saccharomyces cerevisiae., FEBS Lett., 333, 169, 10.1016/0014-5793(93)80398-E
Turner, 2015, A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease., Neurology, 85, 1383, 10.1212/WNL.0000000000002035
Uddin, 2016, Neuroprotective effect of Phyllanthus acidus L. on learning and memory impairment in a scopolamine-induced animal model of dementia and oxidative stress: natural wonder for regulating the development and progression of Alzheimer’s disease., Adv. Alzheimers Dis., 5, 53, 10.4236/aad.2016.52005
Ueda, 1993, Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease., Proc. Natl. Acad. Sci. U.S.A., 90, 11282, 10.1073/pnas.90.23.11282
Uhlen, 2015, Proteomics. Tissue-based map of the human proteome., Science, 347, 10.1126/science.1260419
Urbanelli, 2008, Cathepsin D expression is decreased in Alzheimer’s disease fibroblasts., Neurobiol. Aging, 29, 12, 10.1016/j.neurobiolaging.2006.09.005
Vingtdeux, 2010, AMP-activated protein kinase signaling activation by resveratrol modulates amyloid-beta peptide metabolism., J. Biol. Chem., 285, 9100, 10.1074/jbc.M109.060061
Wang, 2016, SNCA gene polymorphism may contribute to an increased risk of Alzheimer’s disease., J. Clin. Lab. Anal., 30, 1092, 10.1002/jcla.21986
Weissman, 2001, Themes and variations on ubiquitylation., Nat. Rev. Mol. Cell Biol., 2, 169, 10.1038/35056563
Wong, 2011, Cdk5-mediated phosphorylation of endophilin B1 is required for induced autophagy in models of Parkinson’s disease., Nat. Cell Biol., 13, 568, 10.1038/ncb2217
Xiao, 2010, A meta-analysis of mood stabilizers for Alzheimer’s disease., J. Huazhong Univ. Sci. Technol. Med. Sci., 30, 652, 10.1007/s11596-010-0559-5
Xie, 2016, UCH-L1 inhibition decreases the microtubule-binding function of tau protein., J. Alzheimers Dis., 49, 353, 10.3233/JAD-150032
Xu, 2011, JNK regulates FoxO-dependent autophagy in neurons., Genes Dev., 25, 310, 10.1101/gad.1984311
Xue, 2006, Genetic association between Ubiquitin Carboxy-terminal Hydrolase-L1 gene S18Y polymorphism and sporadic Alzheimer’s disease in a Chinese Han population., Brain Res., 1087, 28, 10.1016/j.brainres.2006.02.121
Xue, 2013, Upexpression of Beclin-1-dependent autophagy protects against beta-amyloid-induced cell injury in PC12 cells., J. Mol. Neurosci., 51, 180, 10.1007/s12031-013-9974-y
Yamazaki, 2010, Immunopositivity for ESCRT-III subunit CHMP2B in granulovacuolar degeneration of neurons in the Alzheimer’s disease hippocampus., Neurosci. Lett., 477, 86, 10.1016/j.neulet.2010.04.038
Yan, 2014, Overexpression of human E46K mutant alpha-synuclein impairs macroautophagy via inactivation of JNK1-Bcl-2 pathway., Mol. Neurobiol., 50, 685, 10.1007/s12035-014-8738-1
Yang, 2009, Amyloid precursor protein, heat-shock proteins, and Bcl-2 form a complex in mitochondria and modulate mitochondria function and apoptosis in N2a cells., Mech. Ageing Dev., 130, 592, 10.1016/j.mad.2009.07.002
Yang, 2015, Glial fibrillary acidic protein: from intermediate filament assembly and gliosis to neurobiomarker., Trends Neurosci., 38, 364, 10.1016/j.tins.2015.04.003
Ye, 2017, The role of autophagy in pro-inflammatory responses of microglia activation via mitochondrial reactive oxygen species in vitro., J. Neurochem., 142, 215, 10.1111/jnc.14042
Yoshimoto, 1995, NACP, the precursor protein of the non-amyloid beta/A4 protein (A beta) component of Alzheimer disease amyloid, binds A beta and stimulates A beta aggregation., Proc. Natl. Acad. Sci. U.S.A., 92, 9141, 10.1073/pnas.92.20.9141
Yu, 2005, Macroautophagy–a novel Beta-amyloid peptide-generating pathway activated in Alzheimer’s disease., J. Cell Biol., 171, 87, 10.1083/jcb.200505082
Yue, 2015, Association of UBQ-8i polymorphism with Alzheimer’s disease in Caucasians: a meta-analysis., Int. J. Neurosci., 125, 395, 10.3109/00207454.2014.943369
Zhang, 2015, Neuroinflammation in Alzheimer’s disease., Neuropsychiatr. Dis. Treat., 11, 243, 10.2147/NDT.S75546
Zhang, 2014, Clusterin facilitates stress-induced lipidation of LC3 and autophagosome biogenesis to enhance cancer cell survival., Nat. Commun., 5, 10.1038/ncomms6775
Zhang, 2017, Evaluating the effectiveness of GTM-1 rapamycin, and carbamazepine on autophagy and Alzheimer disease., Med. Sci. Monit., 23, 801, 10.12659/MSM.898679
Zhang, 2014, Overexpression of ubiquitin carboxyl-terminal hydrolase L1 (UCHL1) delays Alzheimer’s progression in vivo., Sci. Rep., 4, 10.1038/srep07298
Zhang, 2015, Impacts of PICALM and CLU variants associated with Alzheimer’s disease on the functional connectivity of the hippocampus in healthy young adults., Brain Struct. Funct., 220, 1463, 10.1007/s00429-014-0738-4
Zhang, 2014, Meta-analysis of Ubiquilin1 gene polymorphism and Alzheimer’s disease risk., Med. Sci. Monit., 20, 2250, 10.12659/MSM.891030
Zhang, 2002, Selective cytotoxicity of intracellular amyloid beta peptide1-42 through p53 and Bax in cultured primary human neurons., J. Cell Biol., 156, 519, 10.1083/jcb.200110119
Zhou, 2011, GSK-3beta inhibitors suppressed neuroinflammation in rat cortex by activating autophagy in ischemic brain injury., Biochem. Biophys. Res. Commun., 411, 271, 10.1016/j.bbrc.2011.06.117
Zhou, 2014, Intracellular clusterin interacts with brain isoforms of the bridging integrator 1 and with the microtubule-associated protein Tau in Alzheimer’s disease., PLOS ONE, 9, 10.1371/journal.pone.0103187